Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Merck
AstraZeneca
Johnson and Johnson
Moodys

Last Updated: October 6, 2022

Details for Patent: 6,988,496


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Summary for Patent: 6,988,496
Title:Cartridge for a liquid
Abstract: For meteredly dispensing a liquid over a period of several months from a container which can be stored over a long period of time, the need is for a container which is practically diffusion-tight and in which the liquid does not come into contact with the ambient atmosphere. The cartridge according to the invention is a three-shell container comprising a collapsible bag which contains the liquid, a container which is stable in respect of shape and a stiff metal casing. The cartridge can be releasably connected to a dispensing device. The cartridge can be provided with a micro-opening with which the time for pressure equalisation between the cartridge and the ambient atmosphere can be adjusted. The cartridge is suitable for aqueous and for alcoholic liquids which contain a pharmacologically active substance. The liquid in the cartridge is protected from external influences. The cartridge can be used in an atomiser for producing an inhalable aerosol for the treatment of illnesses.
Inventor(s): Eicher; Joachim (Dortmund, DE), Geser; Johannes (Dortmund, DE), Hausmann; Matthias (Dortmund, DE), Schyra; Michael (Wuppertal, DE), Wuttke; Gilbert (Dortmund, DE), Fiol; Andreas (Wuppertal, DE), Kladders; Heinrich (Muelheim, DE), Hochrainer; Dieter (Bingen am Rhein, DE), Zierenberg; Bernd (Bingen am Rhein, DE)
Assignee: Boehringer Ingelheim International GmbH (DE)
Application Number:09/511,267
Patent Claim Types:
see list of patent claims
Device; Use;

Drugs Protected by US Patent 6,988,496

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,988,496

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany199 40 713Feb 23, 1999
MalaysiaPI 99 00627Aug 26, 1999

International Family Members for US Patent 6,988,496

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 022717 See Plans and Pricing
Austria 277582 See Plans and Pricing
Australia 3422600 See Plans and Pricing
Australia 759881 See Plans and Pricing
Bulgaria 105785 See Plans and Pricing
Bulgaria 64454 See Plans and Pricing
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Merck
McKinsey
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.